ArticleInternational journal of population data science2020
Sensing pedestrian flows for real-time assessment of non-pharmaceutical policy interventions during the COVID-19 pandemic.
Article in International journal of population data science, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: To combat and mitigate the transmission of the SARS-CoV-2 virus, reducing the number of social contacts within a population is highly effective. Non-pharmaceutical policy interventions, e.g. stay-at-home orders, closing schools, universities, and (non-essential) businesses, are expected to decrease pedestrian flows in public areas, leading to reduced social contacts. The extent to which such interventions show the targeted effect is often measured retrospectively by surveying behavioural changes. Approaches that use data generated through mobile phones are hindered by data confidentiality and privacy regulations and complicated by selection effects. Furthermore, access to such sensitive data is limited. However, a complex pandemic situation requires a fast evaluation of the effectiveness of the introduced interventions aiming to reduce social contacts. Location-based sensor systems installed in cities, providing objective measurements of spatial mobility in the form of pedestrian flows, are suited for such a purpose. These devices record changes in a population's behaviour in real-time, do not have privacy problems as they do not identify persons, and have no selection problems due to ownership of a device. Objective: This work aimed to analyse location-based sensor measurements of pedestrian flows in 49 metropolitan areas at 100 locations in Germany to study whether such technology is suitable for the real-time assessment of behavioural changes during a phase of several different pandemic-related policy interventions. Methods: Spatial mobility data of pedestrian flows was linked with policy interventions using the date as a unique linkage key. Data was visualised to observe potential changes in pedestrian flows before or after interventions. Furthermore, differences in time series of pedestrian counts between the pandemic and the pre-pandemic year were analysed. Results: The sensors detected changes in mobility patterns even before policy interventions were enacted. Compared to the pre-pandemic year, pedestrian counts were 85% lower. Conclusions: The study illustrated the practical value of sensor-based real-time measurements when linked with non-pharmaceutical policy intervention data. This study's core contribution is that the sensors detected behavioural changes before enacting or loosening non-pharmaceutical policy interventions. Therefore, such technologies should be considered in the future by policymakers for crisis management and policy evaluation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.